1. Home
  2. YCBD

as of 08-20-2026 12:36pm EST

$0.49
$0.02
-3.35%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Founded: 2015 Country:
United States
United States
Employees: N/A City: CHARLOTTE
Market Cap: 6.0M IPO Year: 2018
Target Price: $2.00 AVG Volume (30 days): 168.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.09 EPS Growth: 39.11
52 Week Low/High: $0.47 - $2.56 Next Earning Date: 05-15-2026
Revenue: $19,190,468 Revenue Growth: -1.50%
Revenue Growth (this year): 12.7% Revenue Growth (next year): 7.00%
P/E Ratio: -0.46 Index: N/A
Free Cash Flow: -1636547.0 FCF Growth: N/A

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q3

Q3 2025 Earnings

8-K

Nov 25, 2025

0001437749-25-036342

Transcript text not available. View on SEC.gov →

2021
Q2

Q2 2021 Earnings

8-K

Aug 12, 2021

0001654954-21-008843

Transcript text not available. View on SEC.gov →

2021
Q1

Q1 2021 Earnings

8-K

May 12, 2021

0001654954-21-005511

Transcript text not available. View on SEC.gov →

Share on Social Networks: